By Mill Chart
Last update: Apr 8, 2024
Consider THE CIGNA GROUP (NYSE:CI) as an affordable growth stock, identified by our stock screening tool. NYSE:CI is showcasing impressive growth figures and is well-positioned in terms of profitability, solvency, and liquidity. Moreover, it seems to be priced reasonably. Let's dive deeper into the analysis.
Every stock receives a Growth Rating from ChartMill, ranging from 0 to 10. This rating assesses various growth aspects, including historical and projected EPS and revenue growth. NYSE:CI boasts a 7 out of 10:
An integral part of ChartMill's stock analysis is the Valuation Rating, which spans from 0 to 10. This rating evaluates diverse valuation factors, including price to earnings and cash flows, while considering the stock's profitability and growth. NYSE:CI has received a 7 out of 10:
ChartMill employs a unique Health Rating system for all stocks. This rating, ranging from 0 to 10, is determined by analyzing various liquidity and solvency ratios. For NYSE:CI, the assigned 5 for health provides valuable insights:
ChartMill assigns a proprietary Profitability Rating to each stock. The score is computed by evaluating various profitability ratios and margins and ranges from 0 to 10. NYSE:CI was assigned a score of 6 for profitability:
Our Affordable Growth screener lists more Affordable Growth stocks and is updated daily.
Our latest full fundamental report of CI contains the most current fundamental analsysis.
This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.
THE CIGNA GROUP
NYSE:CI (4/29/2024, 4:05:00 PM)
After market: 356.44 0 (0%)356.44
+1.97 (+0.56%)
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Besides Wall Street's top -and-bottom-line estimates for Cigna (CI), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
Don't overlook THE CIGNA GROUP (NYSE:CI)—a stock with solid growth prospects and a reasonable valuation.
/PRNewswire/ -- Many American children struggling with mental health challenges do not receive optimal care, and it's exacerbating the damaging ripple effect...
/PRNewswire/ -- In an important step toward driving long-term affordability and access to treatments for chronic and complex conditions, Evernorth Health...
Cigna (CI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
/PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE: CI) today declared a cash dividend of $1.40 per share of its common stock, payable on June 20,...
Between an aging population and increased government spending, investors should consider these three healthcare stocks to buy now.
/PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced today that Brian Evanko, executive vice president and chief financial officer, will...
These are strong buy stocks within the healthcare industry that investors should watch in 2024 due to their strong returns.
Cigna Group could resume its abandoned pursuit of Humana Inc. after the stock prices have moved to the point where a deal makes financial sense, according to Jefferies.